Kurstak Human and Related Viruses

1. Auflage 2013
ISBN: 978-1-4832-7190-3
Verlag: Elsevier Science & Techn.
Format: PDF
Kopierschutz: 1 - PDF Watermark

E-Book, Englisch, 572 Seiten, Web PDF

Comparative Diagnosis of Viral Diseases, II: Human and Related Viruses Part B, is devoted to the diagnosis of viral diseases, and is based on the new comparative unifying concept of the viral world. The work demonstrates that the comparison of and the discrimination among viruses, according to the criteria of classification of the International Committee on Taxonomy of Viruses and to the diseases caused by these viruses irrespective of the species involved, are essential for their diagnosis and prevention. The book is organized into five parts. Part I contains papers on unclassified viruses while Part II focuses on cancer viruses. Part III examines the role of vaccines and chemotherapy in the control of viral diseases. Part IV discusses the development of the development of the WHO reporting system on virus diseases. Part V deals with viral diagnostic reagents and newer diagnostic methods. This book will interest all clinical virologists and immunologists and veterinarians and research workers. It is addressed particularly to the professionals of public health and veterinary sciences who work in the area of diagnosis and control of viral diseases and to those who are interested in the problem of the relation between viruses and cancer.

Autoren/Hrsg.

Kurstak, Edouard

Kurstak, Christine

Inhaltsverzeichnis

1;Front Cover;1
2;Human and Related Viruses, Part B;4
3;Copyright Page;5
4;Table of Contents;6
5;List of Contributors;12
6;Preface;14
7;Contents of Volume I;16
8;Part I: UNCLASSIFIED VIRUSES;18
8.1;Chapter 1. Marburg Virus Disease;20
8.1.1;I. Introduction;20
8.1.2;II. Description of Virus;21
8.1.3;III. Comparative Biology;26
8.1.4;IV. Immunity;36
8.1.5;V. Epidemiology;38
8.1.6;VI. Comparative Diagnosis;40
8.1.7;VII. Prevention and Control;46
8.1.8;References;48
8.2;Chapter 2. Diagnosis of Hepatitis Viral Infections;52
8.2.1;I. Introduction;53
8.2.2;II. The Pathology of Viral Hepatitis;54
8.2.3;III. Hepatitis B;55
8.2.4;IV. Hepatitis A;87
8.2.5;V. Immunization against Hepatitis;92
8.2.6;References;97
8.3;Chapter 3. Slow Virus Infections: Comparative Aspects and Diagnosis;104
8.3.1;I. Introduction;104
8.3.2;II. Progressive Multifocal Leukoencephalopathy;106
8.3.3;III. Subacute Sclerosing Panencephalitis;111
8.3.4;IV. Creutzfeldt-Jakob Disease;116
8.3.5;V. Concluding Remarks;122
8.3.6;References;122
9;Part II: CANCER VIRUSES;126
9.1;Chapter 4. Human Proliferative Diseases and Viruses;128
9.1.1;I. Introduction;129
9.1.2;II. Viruses Associated with Neoplasia of Animals;132
9.1.3;III. Biochemical and Molecular Methods in Studies of Viral Involvement in Animal and Human Neoplasia;154
9.1.4;IV. Search for Human Tumor Viruses;162
9.1.5;V. Molecular and Biochemical Studies in Human Neoplasia;169
9.1.6;VI. Immunological Approaches to the Study of Viruses in Human Neoplasia;179
9.1.7;VII. Herpesviruses and Human Neoplasia;183
9.1.8;VIII. Concluding Remarks;200
9.1.9;References;204
10;Part III: CONTROL OF VIRAL DISEASES: VACCINES AND CHEMOTHERAPY;224
10.1;Chapter 5. Control of Viral Diseases by Vaccines;226
10.1.1;I. Introduction;227
10.1.2;II. Vaccines in Current Use;230
10.1.3;III. Combined and Simultaneous Administration of Viral Vaccines;249
10.1.4;IV. Immunization Practices against Viral Diseases in the United States and Canada;250
10.1.5;V. Immunization Recommendations for Travelers;255
10.1.6;VI. Prospects for New Viral Vaccines;256
10.1.7;References;260
10.2;Chapter 6. Chemotherapy of Viral Diseases: Present Status and Future Prospects;266
10.2.1;I. Introduction;267
10.2.2;II. General Considerations;267
10.2.3;III. Nucleoside Analogs;269
10.2.4;IV. The Interferons;285
10.2.5;V. Miscellaneous Antivirais;292
10.2.6;VI. Immune Potentiators;301
10.2.7;VII. Antiviral Perspectives;303
10.2.8;References;306
11;Part IV: VIRUS INFORMATION SYSTEM;314
11.1;Chapter 7. The World Health Organization Virus Information System;316
11.1.1;I. Introduction;317
11.1.2;II. Development of the Reporting System;317
11.1.3;III. Objectives;319
11.1.4;IV. Data Input from Laboratories;320
11.1.5;V. Limitations to the Input;324
11.1.6;VI. Data Processing;325
11.1.7;VII. Output;327
11.1.8;VIII. Limitations of the Output;344
11.1.9;IX. Noncomputerized Information;347
11.1.10;X. Information System for Influenza Surveillance;347
11.1.11;XI. Use of Excess Mortality from Respiratory Diseases in the Study of Influenza;350
11.1.12;XII. Arboviruses, Rickettsiae, and Chlamydiae;350
11.1.13;XIII. Future of the WHO Virus Reporting System;351
11.1.14;XIV. World Health Organization [Collaborating Centres (Virus Diseases)];352
11.1.15;References;360
12;Part V: DIAGNOSTIC REAGENTS AND NEWER METHODS;362
12.1;Chapter 8. Viral Diagnostic Reagents;364
12.1.1;I. Introduction;365
12.1.2;II. Historical Background;371
12.1.3;III. Inactivation;378
12.1.4;IV. Adenoviruses;382
12.1.5;V. Herpesvirus hominis (Simplex);386
12.1.6;VI. Varicella-Zoster Virus;389
12.1.7;VII. Cytomegaloviruses;390
12.1.8;VIII. Poxviruses;393
12.1.9;IX. Orthomyxoviruses (Influenza);396
12.1.10;X. Paramyxoviruses (Parainfluenza);400
12.1.11;XI. Mumps;403
12.1.12;XII. Measles;405
12.1.13;XIII. Respiratory Syncytial Virus;408
12.1.14;XIV. Arboviruses;409
12.1.15;XV. Rubella;413
12.1.16;XVI. Rotaviruses (Infantile Gastroenteritis Virus);416
12.1.17;References;417
12.2;Chapter 9. Immunoperoxidase Technique in Diagnostic Virology and Research: Principles and Applications;420
12.2.1;I. Introduction;421
12.2.2;II. Reagents;423
12.2.3;III. Methods of Conjugation;432
12.2.4;IV. Procedures for Detection of Viral Antigens in Cells;441
12.2.5;V. Applications and Perspectives in Diagnosis and Research;453
12.2.6;VI. Conclusions;459
12.2.7;References;460
12.3;Chapter 10. Enzyme Immunoassays and Their Potential in Diagnositc Virology;466
12.3.1;I. Introduction;466
12.3.2;II. Materials and Methods;468
12.3.3;III. Results;470
12.3.4;IV. Conclusions;474
12.3.5;References;474
12.4;Chapter 11. Radioimmunoassay in Viral Diagnosis;476
12.4.1;I. Introduction;476
12.4.2;II. Methods and Reagents;478
12.4.3;III. Applications;492
12.4.4;References;501
12.5;Chapter 12. Cytohybridization Techniques in Virology;506
12.5.1;I. Introduction;506
12.5.2;II. Basic Principles of Hybridization;507
12.5.3;III. Requirements in Cytohybridization;508
12.5.4;IV. Preparation of the Radioactive Probes;509
12.5.5;V. Procedures for in Situ Hybridization;512
12.5.6;VI. Applications in Research and Diagnosis;518
12.5.7;VII. Conclusions and Prospects;519
12.5.8;VIII. Glossary;519
12.5.9;References;520
12.6;Chapter 13. Electron and Immunoelectron Microscopic Procedures for Diagnosis of Viral Infections;522
12.6.1;I. Introduction;523
12.6.2;II. Establishing an EM Unit for Virology;524
12.6.3;III. Direct Examination of Clinical Specimens by Negative Staining;526
12.6.4;IV. Direct Examination of Clinical Specimens by Thin Sectioning;534
12.6.5;V. Identification of Viruses Isolated in Tissue Cultures, Eggs, and Animals;536
12.6.6;VI. Screening Cell Cultures and Virus Pools for Adventitious Agents;542
12.6.7;VII. Immunoelectron Microscopy;547
12.6.8;VIII. Safety Precautions;552
12.6.9;References;554
13;Index;558